Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability. Lorna Rothery spoke to the team about the effects of pharmaceutical pollution and the necessity for the industry to adopt greener practices.
With attention turning in the U.S. and elsewhere to how cannabis businesses are banked, John Binns, Partner at BCL Solicitors LLP, gets into the weeds of how UK banks have been addressing the issue, as well as the prospects for improvement.
Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.
Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
Louise O’Neill from SSPC, the SFI Research Centre for Pharmaceuticals, underlines the importance of training the next generation of highly skilled pharmaceutical scientists and engineers in Ireland.
Rich Pugh, Chief Data Scientist at Mango Solutions, discusses how data science can be used for good, with a particular focus on the provision of medication and helping create a more efficient NHS.
